{"certainAgreement":{"otherDetails":"The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ClinicalTrialsDisclosure@msd.com","organization":"Merck Sharp & Dohme LLC","phone":"1-800-672-6372","title":"Senior Vice President, Global Clinical Development"}}